Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003978-16Phase 2Completed
Phase 2, randomised trial of Fibrinogen human in Bleeding and post-traumatic hemorrhage (2 arms), sponsored by Capitol Region Blood Bank. Primary endpoint: TEG FF MA at initial post-intervention timepoint. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003978-16.